DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Blood Bilirubin Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Blood Bilirubin Increased (83)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include blood bilirubin increased. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 83   Next >>

Possible Cytarabine side effects in 4 year old female

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)

Reactions: Blood Bilirubin Increased, Hyponatraemia, Hypernatraemia, Caecitis, Hypokalaemia, Hypophosphataemia, Left Ventricular Dysfunction, Cardiac Failure, Ileus, Diarrhoea, Venoocclusive Liver Disease, Hypocalcaemia, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk, cyclic

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-25

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-07-05

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24



Possible Cytarabine side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-16

Patient: female, weighing 119.8 kg (263.6 pounds)

Reactions: Blood Bilirubin Increased, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-L-Asparaginase (K-H) 6000 MG
    Dosage: 6000 mg

Vincristine Sulfate
    Dosage: 5 mg

Methotrexate
    Dosage: 15 mg

Daunorubicin HCL
    Dosage: 150 mg

Cytarabine
    Dosage: 70 mg



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-31

Patient: male, weighing 89.9 kg (197.8 pounds)

Reactions: Pulmonary Hypertension, Blood Bilirubin Increased, Blood Urea Increased, Body Temperature Increased, Mental Status Changes, Blood Albumin Decreased, Blood Urea Nitrogen / Creatinine Ratio Increased, Cerebral Haemorrhage, Subarachnoid Haemorrhage, Mitral Valve Incompetence, Blood Creatinine Increased, Acute Respiratory Failure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Daunorubicin HCL
    Dosage: 318 mg
    End date: 2012-07-04

Etoposide
    Dosage: 1060 mg
    End date: 2012-07-04

Cytarabine
    Dosage: 3886 mg
    End date: 2012-06-30



Possible Cytarabine side effects in 17 year old female

Reported by a physician from United States on 2012-07-27

Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)

Reactions: Blood Bilirubin Increased, Dysphagia, Muscular Weakness, Vocal Cord Paralysis, Caecitis, Depressed Level of Consciousness, Acute Respiratory Distress Syndrome, Sinus Tachycardia, Peripheral Motor Neuropathy, Spinal Cord Oedema, Neuralgia, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Nelarabine
    Dosage: 650mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-04-13

Vincristine
    Dosage: 1.5mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Cytarabine
    Dosage: 75mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Mercaptopurine
    Dosage: 60mgm2 cyclic
    Administration route: Oral
    Indication: T-Cell Type Acute Leukaemia

PEG-Asparaginase
    Indication: T-Cell Type Acute Leukaemia

Methotrexate
    Indication: T-Cell Type Acute Leukaemia

Dalteparin Sodium
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Vancomycin; Nystatin; Piperacillin and Tazobactam; Insulin Aspart; Lansoprazole; Voriconazole



Possible Cytarabine side effects in 17 year old female

Reported by a physician from United States on 2012-07-25

Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)

Reactions: Blood Bilirubin Increased, Dysphagia, Muscular Weakness, Vocal Cord Paralysis, Cerebrovascular Accident, Caecitis, Eating Disorder, Diarrhoea, Depressed Level of Consciousness, Acute Respiratory Distress Syndrome, Sinus Tachycardia, Spinal Cord Oedema, Peripheral Motor Neuropathy, Epistaxis, Neuralgia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Nelarabine
    Dosage: 650mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-04-13

PEG-Asparaginase
    Indication: T-Cell Type Acute Leukaemia

Mercaptopurine
    Dosage: 60mgm2 cyclic
    Administration route: Oral
    Indication: T-Cell Type Acute Leukaemia

Dalteparin Sodium
    Indication: Product Used FOR Unknown Indication

Methotrexate
    Indication: T-Cell Type Acute Leukaemia

Cyclophosphamide
    Dosage: 1000mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Cytarabine
    Dosage: 75mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Vincristine
    Dosage: 1.5mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Other drugs received by patient: Insulin Aspart; Lansoprazole; Vancomycin; Nystatin; Piperacillin and Tazobactam; Voriconazole



Possible Cytarabine side effects in 4 year old female

Reported by a consumer/non-health professional from United States on 2012-07-24

Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)

Reactions: Blood Bilirubin Increased, Hyponatraemia, Hypernatraemia, Caecitis, Hypokalaemia, Hypophosphataemia, Left Ventricular Dysfunction, Diarrhoea, Ileus, Cardiac Failure, Venoocclusive Liver Disease, Hypocalcaemia, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-26

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-25



Possible Cytarabine side effects in 17 year old female

Reported by a physician from United States on 2012-07-13

Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)

Reactions: Blood Bilirubin Increased, Dysphagia, Muscular Weakness, Vocal Cord Paralysis, Cerebrovascular Accident, Caecitis, Eating Disorder, Diarrhoea, Depressed Level of Consciousness, Acute Respiratory Distress Syndrome, Spinal Cord Oedema, Peripheral Motor Neuropathy, Sinus Tachycardia, Neuralgia, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Asparaginase
    Indication: T-Cell Type Acute Leukaemia

Cyclophosphamide
    Dosage: 1000mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Cytarabine
    Dosage: 75mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Nelarabine
    Dosage: 650mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-04-13

Methotrexate
    Indication: T-Cell Type Acute Leukaemia

Dalteparin Sodium
    Indication: Product Used FOR Unknown Indication

Vincristine
    Dosage: 1.5mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Mercaptopurine
    Dosage: 60mgm2 cyclic
    Administration route: Oral
    Indication: T-Cell Type Acute Leukaemia

Other drugs received by patient: Insulin Aspart; Nystatin; Voriconazole; Vancomycin; Piperacillin and Tazobactam; Lansoprazole



Possible Cytarabine side effects in 17 year old female

Reported by a physician from United States on 2012-07-09

Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)

Reactions: Blood Bilirubin Increased, Dysphagia, Cerebrovascular Accident, Caecitis, Eating Disorder, Dysphonia, Diarrhoea, Acute Respiratory Distress Syndrome, Depressed Level of Consciousness, Peripheral Motor Neuropathy, Sinus Tachycardia, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Indication: T-Cell Type Acute Leukaemia

Vincristine
    Dosage: 1.5mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Mercaptopurine
    Dosage: 60mgm2 cyclic
    Administration route: Oral
    Indication: T-Cell Type Acute Leukaemia

Nelarabine
    Dosage: 650mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-04-13

Cyclophosphamide
    Dosage: 1000mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Dalteparin Sodium
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 75mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

PEG-Asparaginase
    Indication: T-Cell Type Acute Leukaemia

Other drugs received by patient: Lansoprazole; Piperacillin and Tazobactam; Vancomycin; Voriconazole; Insulin Aspart; Nystatin



Possible Cytarabine side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-27

Patient:

Reactions: Blood Bilirubin Increased, Vomiting, Nausea, Anaemia, Rash, Fatigue, Aspartate Aminotransferase Increased, Adverse Event, Neutropenia, Rash Maculo-Papular, Thrombocytopenia, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Administration route: Oral

Revlimid
    Dosage: 10mg-25mg
    Administration route: Oral

Revlimid
    Dosage: 50 milligram
    Administration route: Oral

Revlimid
    Dosage: 10mg-25mg
    Administration route: Oral

Cytarabine
    Dosage: 1.5 milligram/sq. meter

Cytarabine
    Dosage: 10 milligram



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from United States on 2012-06-22

Patient: male, weighing 13.6 kg (29.9 pounds)

Reactions: Blood Bilirubin Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 50 mg

Vincristine Sulfate
    Dosage: 3.6 mg

Dexamethasone Sodium Phosphate
    Dosage: 98 mg

Other drugs received by patient: Bactrim; Propofol



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from United States on 2012-06-18

Patient: male, weighing 101.8 kg (224.0 pounds)

Reactions: Blood Bilirubin Increased, Confusional State, Blood Potassium Increased, Faecal Incontinence, Blood Creatinine Increased, Blood Sodium Decreased, Diabetic Hyperosmolar Coma, Blood Glucose Increased, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 1820 mg

Cytarabine
    Dosage: 70 mg

Daunorubicin HCL
    Dosage: 110 mg

PEG-L-Asparaginase (K-H)
    Dosage: 5500 iu

Vincristine
    Dosage: 4 mg

Other drugs received by patient: Insulin; Omeprazole; Valacyclovir Hydrochloride; Allopurinol; Vancomycin; Buprenorphine HCL and Naloxone HCL; Moxifloxacin; Fluconazole



Possible Cytarabine side effects in 17 year old female

Reported by a physician from United States on 2012-06-08

Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)

Reactions: Blood Bilirubin Increased, Pyrexia, Caecitis, Loss of Consciousness, Oedema Peripheral, Pulmonary Oedema, Hypocalcaemia, Acute Respiratory Distress Syndrome, Melaena, Hypertriglyceridaemia, Epistaxis, Dysphagia, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Eating Disorder, Tremor, Cerebral Infarction, Depressed Level of Consciousness, Neutropenia, Confusional State, Dyskinesia, Somnolence, Splenic Infarction, Hypokalaemia, Pleural Effusion, White Blood Cell Count Decreased, Cerebrovascular Accident, Ascites, Diarrhoea, Hypophagia, Hypoalbuminaemia, Sinus Tachycardia, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mercaptopurine
    Dosage: 60mgm2 cyclic
    Administration route: Oral
    Indication: T-Cell Type Acute Leukaemia

Vincristine
    Dosage: 1.5mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Cyclophosphamide
    Dosage: 1000mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Methotrexate
    Indication: T-Cell Type Acute Leukaemia

Oncaspar
    Indication: T-Cell Type Acute Leukaemia

Nelarabine
    Dosage: 650mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-04-13

Cytarabine
    Dosage: 75mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Dalteparin Sodium
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Nystatin; Lansoprazole; Insulin Aspart; Piperacillin and Tazobactam; Vancomycin; Voriconazole



Possible Cytarabine side effects in female

Reported by a individual with unspecified qualification from United States on 2012-06-06

Patient: female, weighing 58.3 kg (128.3 pounds)

Reactions: Blood Bilirubin Increased, Disseminated Intravascular Coagulation, Coagulopathy, Continuous Haemodiafiltration, Blood Culture Positive, Blood Uric Acid Increased, Hepatosplenomegaly, Enterobacter Test Positive, Fluid Overload, Blood Potassium Increased, Respiratory Distress, Candida Test Positive, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Aspartate Aminotransferase Increased, Ventricular Fibrillation, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1467 mg
    End date: 2012-01-30

Daunorubicin HCL
    Dosage: 222 mg
    End date: 2012-01-03

Etoposide
    Dosage: 686 mg
    End date: 2012-01-30



Possible Cytarabine side effects in 17 year old female

Reported by a physician from United States on 2012-05-31

Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)

Reactions: Blood Bilirubin Increased, Cerebrovascular Accident, Eating Disorder, Diarrhoea, Depressed Level of Consciousness, Acute Respiratory Distress Syndrome, Sinus Tachycardia, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Mercaptopurine
    Dosage: 60mgm2 cyclic
    Administration route: Oral
    Indication: T-Cell Type Acute Leukaemia

Cyclophosphamide
    Dosage: 1000mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Cytarabine
    Dosage: 75mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Dalteparin Sodium
    Indication: Product Used FOR Unknown Indication

Methotrexate
    Indication: T-Cell Type Acute Leukaemia

Nelarabine
    Dosage: 650mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-04-13

PEG-Asparaginase
    Indication: T-Cell Type Acute Leukaemia

Other drugs received by patient: Voriconazole; Insulin Aspart; Nystatin; Vancomycin; Lansoprazole; Piperacillin and Tazobactam



Possible Cytarabine side effects in 29 year old female

Reported by a pharmacist from Canada on 2012-05-30

Patient: 29 year old female, weighing 46.0 kg (101.2 pounds)

Reactions: Blood Bilirubin Increased, non-Cardiogenic Pulmonary Oedema, Hypoxia, Acute Respiratory Distress Syndrome

Drug(s) suspected as cause:
Cytarabine



Possible Cytarabine side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-09

Patient: female, weighing 11.1 kg (24.4 pounds)

Reactions: Blood Bilirubin Increased, Pseudomonas Infection, Nuclear Magnetic Resonance Imaging Brain Abnormal, Hepatitis, Blood Culture Positive, Cholangitis, CSF Pressure Increased, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mitoxantrone Hydrochloride
    Dosage: 4 mg
    End date: 2011-11-08

Cytarabine
    Dosage: 2948
    End date: 2011-11-01



Possible Cytarabine side effects in 48 year old female

Reported by a consumer/non-health professional from United States on 2012-05-08

Patient: 48 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Blood Bilirubin Increased, Pneumonia Fungal, Soft Tissue Infection, Alanine Aminotransferase Increased, Febrile Neutropenia, Bronchitis, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mesna
    Dosage: last dose on 07dec11
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-05

Methotrexate
    Dosage: last:28jan2011,20mar12 courses:6 also taken 12mg(last dose on 06dec11)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-05

Vincristine Sulfate
    Dosage: last dose on 8dec11 received 4dose on dec8
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-05

Cyclophosphamide
    Dosage: last dose on 07dec2011
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-05

Doxorubicin HCL
    Dosage: last dose on 08dec2011
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-05

Cytarabine
    Dosage: also taken 100mg(last12dec2011) last dose:31dec11,23mar12 courses:6
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-05

Leucovorin Calcium
    Dosage: last dose on 30dec11,22mar12 courses:6
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-05

Sprycel
    Dosage: dose held d5 d6,7 8 also taken 600mg (last11jan2012) last dose on 14dec2011,5apr12 courses:6
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-05

Methylprednisolone
    Dosage: last dose:21mar12 courses:6
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-05

Dexamethasone
    Dosage: last dose on 08dec2011
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-12-05



Possible Cytarabine side effects in 57 year old male

Reported by a physician from Japan on 2012-04-06

Patient: 57 year old male

Reactions: Blood Bilirubin Increased, Stomatitis, Hyperbilirubinaemia, Gastrointestinal Toxicity, Rash, Pyrexia, Meningitis Viral, Thrombotic Microangiopathy, Convulsion, Pneumonia Cytomegaloviral, Diarrhoea, Hepatotoxicity, Graft Versus Host Disease in Skin, Hypoxia, Altered State of Consciousness, Engraftment Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Fludarabine Phosphate
    Indication: Stem Cell Transplant

Cytarabine
    Indication: Stem Cell Transplant

Melphalan Hydrochloride
    Indication: Stem Cell Transplant

Cyclosporine
    Dosage: 3mgk per day

Other drugs received by patient: Methotrexate



Possible Cytarabine side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-15

Patient: 69 year old female

Reactions: Blood Bilirubin Increased, Death, Hepatotoxicity, Oedema, Palmar-Plantar Erythrodysaesthesia Syndrome, Pyrexia

Adverse event resulted in: death

Drug(s) suspected as cause:
Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Anti-Thymocyte Globulin NOS
    Indication: Bone Marrow Conditioning Regimen

Acyclovir
    Indication: Antiviral Prophylaxis

Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Cytarabine
    Indication: Chemotherapy

Levofloxacin
    Indication: Antibiotic Prophylaxis

Clofarabine
    Indication: Chemotherapy

Metronidazole
    Indication: Antibiotic Prophylaxis

Fluconazole
    Indication: Antifungal Prophylaxis



Possible Cytarabine side effects in 55 year old female

Reported by a physician from Germany on 2012-03-15

Patient: 55 year old female

Reactions: Mucosal Inflammation, Blood Bilirubin Increased, Hepatotoxicity, Pyrexia

Drug(s) suspected as cause:
Cytarabine
    Indication: Chemotherapy

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Clofarabine
    Indication: Chemotherapy

Levofloxacin
    Indication: Antibiotic Prophylaxis

Acyclovir
    Indication: Antiviral Prophylaxis

Fluconazole
    Indication: Antifungal Prophylaxis

Anti-Thymocyte Globulin NOS
    Indication: Bone Marrow Conditioning Regimen

Metronidazole
    Indication: Antibiotic Prophylaxis

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease



Possible Cytarabine side effects in 19 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-15

Patient: 19 year old male

Reactions: Blood Bilirubin Increased, Vomiting, Nausea, Cystitis Haemorrhagic, Nephropathy Toxic, Palmar-Plantar Erythrodysaesthesia Syndrome, Mucosal Inflammation, Death, Hepatotoxicity, Oedema, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Metronidazole
    Indication: Antibiotic Prophylaxis

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Rabbit Antithymoctye Globulin
    Indication: Bone Marrow Conditioning Regimen

Acyclovir
    Indication: Antiviral Prophylaxis

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Fluconazole
    Indication: Antifungal Prophylaxis

Clofarabine
    Indication: Chemotherapy

Cytarabine
    Indication: Chemotherapy

Levofloxacin
    Indication: Antibiotic Prophylaxis



Possible Cytarabine side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-15

Patient: 62 year old male

Reactions: Death, Blood Bilirubin Increased, Hepatotoxicity, Nephropathy Toxic, Oedema, Palmar-Plantar Erythrodysaesthesia Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Cytarabine
    Indication: Chemotherapy

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Levofloxacin
    Indication: Antibiotic Prophylaxis

Fluconazole
    Indication: Antifungal Prophylaxis

Rabbit Antithymocyte Globulin
    Indication: Bone Marrow Conditioning Regimen

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Metronidazole
    Indication: Antibiotic Prophylaxis

Acyclovir
    Indication: Antiviral Prophylaxis

Clofarabine
    Indication: Chemotherapy



Possible Cytarabine side effects in 35 year old female

Reported by a physician from Germany on 2012-03-15

Patient: 35 year old female

Reactions: Blood Bilirubin Increased, Death, Hepatotoxicity, Cystitis Haemorrhagic, Pyrexia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Thymoglobulin
    Indication: Bone Marrow Conditioning Regimen

Acyclovir
    Indication: Antiviral Prophylaxis

Levofloxacin
    Indication: Antibiotic Prophylaxis

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Metronidazole
    Indication: Antibiotic Prophylaxis

Fluconazole
    Indication: Antifungal Prophylaxis

Clofarabine
    Indication: Chemotherapy

Cytarabine
    Indication: Chemotherapy



Possible Cytarabine side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-15

Patient: 58 year old male

Reactions: Blood Bilirubin Increased, Mucosal Inflammation, Hepatotoxicity, Cystitis Haemorrhagic, Oedema

Drug(s) suspected as cause:
Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Clofarabine
    Indication: Chemotherapy

Cytarabine
    Indication: Chemotherapy

Levofloxacin
    Indication: Antibiotic Prophylaxis

Metronidazole
    Indication: Antibiotic Prophylaxis

Fluconazole
    Indication: Antifungal Prophylaxis

Acyclovir
    Indication: Antiviral Prophylaxis

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Anti-Thymocyte Globulin NOS
    Indication: Bone Marrow Conditioning Regimen



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-15

Patient: 50 year old female

Reactions: Mucosal Inflammation, Blood Bilirubin Increased, Hepatotoxicity, Herpes Simplex Ophthalmic, Oedema, Palmar-Plantar Erythrodysaesthesia Syndrome

Drug(s) suspected as cause:
Cytarabine
    Indication: Chemotherapy

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Fluconazole
    Indication: Antifungal Prophylaxis

Levofloxacin
    Indication: Antibiotic Prophylaxis

Acyclovir
    Indication: Antiviral Prophylaxis

Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Clofarabine
    Indication: Chemotherapy

Rabbit Antithymocyte Globulin
    Indication: Bone Marrow Conditioning Regimen

Metronidazole
    Indication: Antibiotic Prophylaxis



Possible Cytarabine side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-15

Patient: 64 year old male

Reactions: Blood Bilirubin Increased, Vomiting, Nausea, Skin Toxicity, Candida Sepsis, Death, Hepatotoxicity, Oedema

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Anti-Thymocyte Globulin NOS
    Indication: Bone Marrow Conditioning Regimen

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Fluconazole
    Indication: Antifungal Prophylaxis

Levofloxacin
    Indication: Antibiotic Prophylaxis

Clofarabine
    Indication: Chemotherapy

Cytarabine
    Indication: Chemotherapy

Metronidazole
    Indication: Antibiotic Prophylaxis

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Acyclovir
    Indication: Antibiotic Prophylaxis



Possible Cytarabine side effects in 69 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-15

Patient: 69 year old male

Reactions: Death, Blood Bilirubin Increased, Hepatotoxicity, Nausea, Atrial Flutter, Sepsis, Palmar-Plantar Erythrodysaesthesia Syndrome, Atrial Fibrillation, Myocardial Infarction

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Fluconazole
    Indication: Antifungal Prophylaxis

Cytarabine
    Indication: Chemotherapy

Acyclovir
    Indication: Antiviral Prophylaxis

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Metronidazole
    Indication: Antibiotic Prophylaxis

Clofarabine
    Indication: Chemotherapy

Levofloxacin
    Indication: Antibiotic Prophylaxis

Rabbit Antithymocyte Globulin
    Indication: Bone Marrow Conditioning Regimen

Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen



Possible Cytarabine side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-15

Patient: 52 year old male

Reactions: Blood Bilirubin Increased, Vomiting, Hepatotoxicity, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Streptococcal Sepsis, Decreased Appetite

Drug(s) suspected as cause:
Clofarabine
    Indication: Chemotherapy

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Levofloxacin
    Indication: Antibiotic Prophylaxis

Metronidazole
    Indication: Antibiotic Prophylaxis

Acyclovir
    Indication: Antiviral Prophylaxis

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Cytarabine
    Indication: Chemotherapy

Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Rabbit Antithymocyte Globulin
    Indication: Bone Marrow Conditioning Regimen

Fluconazole
    Indication: Antifungal Prophylaxis



Possible Cytarabine side effects in 42 year old male

Reported by a physician from Germany on 2012-03-15

Patient: 42 year old male

Reactions: Death, Blood Bilirubin Increased, Mucosal Inflammation, Hepatotoxicity, Staphylococcal Infection, Skin Toxicity

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Indication: Chemotherapy

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Metronidazole
    Indication: Antibiotic Prophylaxis

Acyclovir
    Indication: Antifungal Prophylaxis

Levofloxacin
    Indication: Antibiotic Prophylaxis

Clofarabine
    Indication: Chemotherapy

Fluconazole
    Indication: Antifungal Prophylaxis

Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Anti-Thymocyte Globulin NOS
    Indication: Bone Marrow Conditioning Regimen

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease



Possible Cytarabine side effects in 33 year old male

Reported by a physician from Germany on 2012-03-15

Patient: 33 year old male

Reactions: Blood Bilirubin Increased, Death, Hepatotoxicity, Nausea, Oedema, Pyrexia

Adverse event resulted in: death

Drug(s) suspected as cause:
Acyclovir
    Indication: Antiviral Prophylaxis

Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Thymoglobulin
    Indication: Bone Marrow Conditioning Regimen

Mycophenolate Mofetil
    Indication: Prophylaxis Against Graft Versus Host Disease

Fluconazole
    Indication: Antifungal Prophylaxis

Metronidazole
    Indication: Antibiotic Prophylaxis

Clofarabine
    Indication: Chemotherapy

Levofloxacin
    Indication: Antibiotic Prophylaxis

Cytarabine
    Indication: Chemotherapy



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017